Siegfried Wassenberg

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

Christian Antoni, Arthur Kavanaugh, Bruce Kirkham et al. · Arthritis & Rheumatism · 2005 · 643 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Very low‐dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double‐blind, placebo‐controlled trial

Siegfried Wassenberg, Rolf Rau, Paul Steinfeld et al. · Arthritis & Rheumatism · 2005 · 307 citations

Medicine, Clinical Sciences, Pharmacotherapy +14

Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: Comparison of patients according to their eligibility for major randomized clinical trials

A. Zink, Anja Strangfeld, Matthias Schneider et al. · Arthritis & Rheumatism · 2006 · 231 citations

Medicine, Immunology, Pharmacotherapy +17

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)

Hans‐Peter Tony, Gerd R Burmester, Hendrik Schulze‐Koops et al. · Arthritis Research & Therapy · 2011 · 208 citations · Full text

Life Sciences, Dermatology, Immunology +16

Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?

Joachim Listing, Anja Strangfeld, Jörn Kekow et al. · Arthritis & Rheumatism · 2008 · 195 citations

Medicine, Internal Medicine, Pharmacotherapy +17